# Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases

> **NCT02162537** · PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Intercommunal Creteil** · enrollment: 95 (actual)

## Conditions studied

- Non-small Cell Lung Cancer Metastatic
- Non-small Cell Lung Cancer
- Adenocarcinoma of Lung Metastatic to Brain
- Cerebral Metastases

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Pemetrexed
- **DRUG:** Bevacizumab
- **RADIATION:** Cerebral Radiotherapy

## Key facts

- **NCT ID:** NCT02162537
- **Lead sponsor:** Centre Hospitalier Intercommunal Creteil
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2018-03
- **Final completion:** 2019-01
- **Target enrollment:** 95 (ACTUAL)
- **Why stopped:** Slow inclusions due in part to a change in practices. The first chemotherapy become a standard for patients with NSCL with asymptomatic brain metastases.
- **Last updated:** 2019-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02162537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02162537, "Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02162537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*